From: Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Characteristics | Total population (n = 181) n (%) | Before vaccination (n = 139) n (%) | After vaccination (n = 108) n (%) | |
---|---|---|---|---|
Sex | M | 88 (48.6) | 69 (49.6) | 54 (50.0) |
F | 93 (51.4) | 70 (50.4) | 54 (50.0) | |
Chronic Illness | No | 80 (57.6) | ||
Yes | 59 (42.4) | |||
Medication use | No | 82 (59.0) | ||
Yes | 34 (24.5) | |||
Unknown | 23 (16.5) | |||
Medical intervention | No | 111 (79.9) | ||
Yes | 5 (3.6) | |||
Unknown | 23 (16.5) | |||
Other complaints | No | 108 (77.7) | ||
Yes | 8 (5.8) | |||
Unknown | 23 (16.5) | |||
Ill on day immunization | No | 104 (96.3) | ||
Yes | 4 (3.7) |